RecruitingEarly Phase 1NCT07339332

A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus

Studying Pediatric systemic lupus erythematosus

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Intervention
CAR-T Therapy(other)
Enrollment
12 target
Eligibility
18-65 years · All sexes
Timeline
2026 – 2027

Study locations (1)

Collaborators

CARsgen Therapeutics Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07339332 on ClinicalTrials.gov

Other trials for Pediatric systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

See all trials for Pediatric systemic lupus erythematosus →

← Back to all trials